HER2 in Gastric Cancer: An Immunohistochemical Study on Tissue Microarrays and the Coressponding Whole-Tissue Sections with a Supplemental Fish Study

被引:11
|
作者
Gasljevic, Gorana [1 ]
Lamovec, Janez [1 ]
Contreras, Juan Antonio [1 ]
Zadnik, Vesna [2 ]
Blas, Mateja [1 ]
Gasparov, Slavko [3 ,4 ]
机构
[1] Inst Oncol, Dept Pathol, Ljubljana 1000, Slovenia
[2] Inst Oncol, Canc Registry, Ljubljana 1000, Slovenia
[3] Univ Hosp Merkur, Dept Pathol, Zagreb 10000, Croatia
[4] Univ Zagreb, Sch Med, Zagreb 10000, Croatia
关键词
FISH; Gastric carcinoma; HER2; Immunohistochemistry; TMA; Whole sections; IN-SITU HYBRIDIZATION; GENE AMPLIFICATION; PROGNOSTIC-FACTOR; CARCINOMA; EXPRESSION; ASSOCIATION; VALIDATION; SURVIVAL; RECEPTOR;
D O I
10.1007/s12253-013-9654-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Since focal HER2 expression is an issue in GC, TMA construction from the paraffin-embedded surgically-obtained tissue may not reflect its real status. The aim of this study was to assess the HER2 status in tissue microarrays (TMAs) and the corresponding whole sections using HercepTest immunohistochemistry (IHC), and to correlate it and to assess the concordance of HER2 IHC and fluorescence in situ hybridization (FISH) in TMAs. Concordance of the HER2 expression status for 302 cases of gastric cancer using 9 paired TMAs was evaluated using a 2-mm core size and 305 corresponding whole sections. Concordance of the IHC and FISH HER2 status was compared. In addition,, the HER2 status was compared to clinicopathological characteristics and patients' survival. Using the whole-section approach, HER2 over-expression was found in 25.2 % (HER2 3+ 6.6 %, HER2 2+ 18.7 %) of tumours. The overall concordance of IHC between the cores and the whole section was 84.9 %; 15.1 % of the tumours showed HER2 amplification. The overall concordance of IHC and FISH on cores was 75.7 %. The level of amplification correlated with the IHC score. Relationship between the intestinal and papillary types and tumour grade was observed for tumours with over-expression and amplification, whereas tumour location was related only to over-expression. There was a statistically significant difference in the overall survival of the patients, which was related to HER2 amplification. In conclusion, good concordance of the IHC HER2 results between tissue cores in TMA and whole sections, and excellent concordance of the IHC and FISH results on tissue cores was found. At least a part of the observed IHC HER2 heterogeneity could very likely be explained by fixation artifacts. With adequate fixation, a higher concordance of IHC HER2 between the cores and the whole sections can be expected. The TMA approach could enable an easier analysis of more than one representative tumour block.
引用
收藏
页码:855 / 865
页数:11
相关论文
共 50 条
  • [31] Tissue microarray technology in breast cancer HER2 diagnostics
    Egervari, Kristof
    Szollosi, Zoltan
    Nemes, Zoltan
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (03) : 169 - 177
  • [32] Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer
    Shi, Hong-Zhi
    Wang, Yu-Ning
    Huang, Xiao-Hui
    Zhang, Ke-Cheng
    Xi, Hong-Qing
    Cui, Jian-Xin
    Liu, Guo-Xiao
    Liang, Wen-Tao
    Wei, Bo
    Chen, Lin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (10) : 1836 - 1842
  • [33] Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections
    Muftah, Abir A.
    Aleskandarany, Mohammed A.
    Al-kaabi, Methaq M.
    Sonbul, Sultan N.
    Diez-Rodriguez, Maria
    Nolan, Chris C.
    Caldas, Carlos
    Ellis, Ian O.
    Rakha, Emad A.
    Green, Andrew R.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (02) : 341 - 348
  • [34] Dual HER2 Gene Protein Assay Focused Study of Breast Cancers With 2+Immunohistochemical Expression
    Li, Zaibo
    Dabbs, David J.
    Cooper, Kristine L.
    Bhargava, Rohit
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (03) : 451 - 458
  • [35] Evaluation of HER2/neu oncoprotein in serum & tissue samples of women with breast cancer
    Shukla, Shailaja
    Singh, Bhawana Komal
    Pathania, Om Prakash
    Jain, Manjula
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 143 : 52 - 58
  • [36] HER2/neu Expression and Gene Alterations in Pancreatic Ductal Adenocarcinoma: A Comparative Immunohistochemistry and Chromogenic in Situ Hybridization Study Based on Tissue Microarrays and Computerized Image Analysis
    Tsiambas, Evangelos
    Karameris, Andreas
    Dervenis, Christos
    Lazaris, Andreas C.
    Giannakou, Niki
    Gerontopoulos, Kyriakos
    Patsouris, Efstratios
    JOURNAL OF THE PANCREAS, 2006, 7 (03): : 283 - 294
  • [37] Evaluation of HER2/neu oncoprotein in serum and tissue samples of women with breast cancer: Correlation with clinicopathological parameters
    Farzadnia, Mehdi
    Meibodi, Naser Tayyebi
    Shandiz, Fatemeh Homayi
    Mahmoudi, Mahmoud
    Bahar, Mostafa Mehrabi
    Memar, Bahram
    Amoian, Sakineh
    Maroozi, Farshad
    Moheghi, Nasrin
    BREAST, 2010, 19 (06): : 489 - 492
  • [38] The risk of weekend biopsy: Impact of specimen source and fixation status on HER2 assessment in the treatment of advanced gastric cancer (The HER_WEEKEND study)
    Nakamura, Michio
    Watanabe, Ayako
    Yoshizawa, Aki
    Iwasaki, Sari
    Nomura, Asako
    Matsumura, Mariko
    Murai, Taichi
    Itaya, Kazufumi
    Koike, Yuta
    Izumi, Takaaki
    Endo, Ayana
    Kato, Shin
    Ono, Yuji
    Ohshima, Takahiro
    Okazaki, Nanase
    Nakagawa, Shimpei
    Ishii, Yasushi
    Fukasawa, Yuichiro
    Yokota, Isao
    Tsuji, Takahiro
    Nishikawa, Shuji
    PATHOLOGY INTERNATIONAL, 2023, 73 (10) : 509 - 519
  • [39] The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples
    Grillo, Federica
    Fassan, Matteo
    Ceccaroli, Chiara
    Giacometti, Cinzia
    Curto, Monica
    Zagonel, Vittorina
    Ceppa, Paola
    Nitti, Donato
    Castoro, Carlo
    Fiocca, Roberto
    Rugge, Massimo
    Mastracci, Luca
    TRANSLATIONAL ONCOLOGY, 2013, 6 (01): : 10 - 16
  • [40] Re-evaluation of HER2 status in 606 breast cancers-gene protein assay on tissue microarrays versus routine pathological assessment
    Sanden, Emma
    Khazaei, Somayeh
    Tryggvadottir, Helga
    Borgquist, Signe
    Isaksson, Karolin
    Jirstrom, Karin
    Jernstrom, Helena
    VIRCHOWS ARCHIV, 2020, 477 (02) : 317 - 320